(102) have demonstrated that hsa_circ_0007255 plays a new oncogene role in the occurrence and development of BC by regulating the miR-335-5p/SIX2 axis and is expected to become a biomarker for the treatment of BC. This evidence concerns the gene SIX2 and breast cancer.